Vivmark Residential (VMRK)

NYSEReal EstateReit - ResidentialSnapshot 2026-10-16

$61.26+0.13%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 16, 2026

What could strengthen or challenge Vivmark Residential’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+4.1%

+10% or more+5%0%−5%−10% or less

1.65 → 1.72 EPS · FY ending Dec 31, 2027 · 6 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 16, 2026 to Oct 16, 2026: (new ÷ prior − 1). Contributor count changed from 6 to 6; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

Three key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Maintain quarterly dividend payments around $0.70 per share	The company has maintained a stable dividend around $0.70 per share.	Intact	dividend falls below $0.69 per share	Dividend per share: $0.70 per share FY2026-Q2; GAAP. Published target: >=0.70. Target period is not explicitly aligned with this observation. Source published Jul 30, 20260.7025 USD/share · source valueSource reportLast status assessment Oct 16, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 4ee94135-24d4-4704-a9ea-5372dd86663b. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated or implied in 6 of last 6 quarters. Dividend per share remained stable around $0.69 to $0.70 from 2024-Q3 through 2026-Q2, showing consistent capital return to shareholders. The trajectory is delivering steady dividend payments as management has maintained. Delivery assessment Oct 16, 2026
Increase net income to at least $114.1 million	Strong net income growth supports its operational performance.	Intact	falls below $100 million next fiscal quarter	Net income: $114.135M FY2026-Q2; GAAP. Published target: >=114.1 million. Target period is not explicitly aligned with this observation. Source published Jul 30, 2026114,135,000 USD · source valueSource reportLast status assessment Oct 16, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 4ee94135-24d4-4704-a9ea-5372dd86663b. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated or implied in 6 of last 6 quarters. Net income rose from $90.1M in 2026-Q1 to $114.1M in 2026-Q2, and diluted EPS increased from $0.24 to $0.30 in the same period. Earlier quarters show higher net income and EPS variability. The trajectory shows recent growth in earnings, consistent with management's operational focus. Delivery assessment Oct 16, 2026
Revenue growth of 29% YoY	A primary condition in Vivmark Residential's published investment case. The stated target is >=29% YoY.	Intact	falls below 20% YoY growth next fiscal year	Revenue growth: 2.11% FY2026-Q2; GAAP. Published target: >=29% YoY. Target period is not explicitly aligned with this observation. Source published Jul 30, 20262.109968 percent · calculatedSource reportLast status assessment Oct 16, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated or implied in 6 of last 6 quarters. Net income rose from $90.1M in 2026-Q1 to $114.1M in 2026-Q2, and diluted EPS increased from $0.24 to $0.30 in the same period. Earlier quarters show higher net income and EPS variability. The trajectory shows recent growth in earnings, consistent with management's operational focus. Delivery assessment Oct 16, 2026

Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$1.72

$1.61 → $1.72 · observed estimates

FY2027 revenue$3.33B

$3.33B → $3.33B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-09-01	$1.61	$3,328,301,004	5 / 5
2026-09-02	$1.61	$3,328,301,004	5 / 5
2026-09-03	$1.61	$3,328,301,004	5 / 5
2026-09-04	$1.61	$3,328,301,004	5 / 5
2026-09-05	$1.61	$3,328,301,004	6 / 6
2026-09-06	$1.61	$3,328,301,004	6 / 6
2026-09-07	$1.61	$3,328,301,004	6 / 5
2026-09-08	$1.61	$3,328,301,004	6 / 5
2026-09-09	$1.61	$3,328,301,004	6 / 5
2026-09-10	$1.65	$3,322,816,311	6 / 5
2026-09-11	$1.65	$3,322,816,311	6 / 5
2026-09-12	$1.65	$3,322,816,311	6 / 5
2026-09-13	$1.65	$3,322,816,311	6 / 5
2026-09-14	$1.65	$3,322,816,311	6 / 5
2026-09-15	$1.65	$3,322,816,311	6 / 5
2026-09-16	$1.65	$3,322,816,311	6 / 5
2026-09-17	$1.72	$3,326,569,920	6 / 5
2026-09-18	$1.72	$3,326,569,920	6 / 5
2026-09-19	$1.72	$3,326,569,920	6 / 5
2026-09-20	$1.72	$3,333,315,186	6 / 6
2026-09-21	$1.72	$3,333,315,186	6 / 6
2026-09-22	$1.72	$3,333,315,186	6 / 6
2026-09-23	$1.72	$3,333,315,186	6 / 6
2026-09-24	$1.72	$3,333,315,186	6 / 6
2026-09-25	$1.72	$3,333,315,186	6 / 5
2026-09-26	$1.72	$3,333,315,186	6 / 5
2026-09-27	$1.72	$3,333,315,186	6 / 5
2026-09-28	$1.72	$3,333,315,186	6 / 5
2026-09-29	$1.72	$3,333,315,186	6 / 5
2026-09-30	$1.72	$3,333,315,186	6 / 5
2026-10-01	$1.72	$3,333,315,186	6 / 5
2026-10-02	$1.72	$3,333,315,186	6 / 5
2026-10-03	$1.72	$3,333,315,186	6 / 5
2026-10-04	$1.72	$3,333,315,186	6 / 5
2026-10-05	$1.72	$3,333,315,186	6 / 5
2026-10-06	$1.72	$3,333,315,186	6 / 5
2026-10-07	$1.72	$3,333,315,186	6 / 5
2026-10-08	$1.72	$3,333,315,186	6 / 5
2026-10-09	$1.72	$3,333,315,186	6 / 5
2026-10-10	$1.72	$3,333,315,186	6 / 5
2026-10-11	$1.72	$3,333,315,186	6 / 5
2026-10-12	$1.72	$3,333,315,186	6 / 5
2026-10-13	$1.72	$3,333,315,186	6 / 5
2026-10-14	$1.72	$3,333,315,186	6 / 5
2026-10-15	$1.72	$3,333,315,186	6 / 6
2026-10-16	$1.72	$3,333,315,186	6 / 6

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	11	15
2026-06-01	9	13
2026-07-01	8	15
2026-08-01	8	15
2026-09-01	10	11
2026-10-01	10	12

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 10 Buy / Strong Buy · 12 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades7 maintains

Recent actions · Sep 17–Oct 16 · 7 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

BarclaysOct 14 · prior Sep 2

$75.00 → $74.00-1.3%

Piper SandlerOct 12 · prior Aug 26

$76.00 → $67.00-11.8%

ScotiabankSep 17 · prior Jul 9

$70.00 → $66.00-5.7%

$0$41.80$83.60

0 raises · 3 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 17, 2026–Oct 16, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Maintain quarterly dividend payments around $0.70 per shareDividend per share: $0.70 per share
Increase net income to at least $114.1 millionNet income: $114.135M
Revenue growth of 29% YoYRevenue growth: 2.11%

Next proof point

Oct 27, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.0%Typical daily move · historical

Downside history

-15.8%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Vivmark Residential outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

VMRK represents a stable investment in the Real Estate sector, characterized by its focus on consistent revenue growth and dividend payments. The current thesis state is intact, supported by strong recent financial performance, but confidence remains low due to sector challenges.

What's priced into Vivmark Residential

The market currently reflects a justified valuation with a slight premium compared to peers. There is a low expectations gap, indicating that investors are not overly optimistic or pessimistic about VMRK's future performance.

What the fundamentals likely do

Management has set a goal for 2% Same Store Residential revenue growth in 2026, which is newly established and will require monitoring for execution. Recent results show strong occupancy at 95.7% and rent growth of 3.6%, indicating positive trends, though the dividend payments have been stable but mixed in delivery.

What Vivmark Residential hinges on

The thesis hinges on external factors such as potential interest rate cuts by the Fed, which could benefit Real Estate names like VMRK. Additionally, the performance of sector bellwethers like AVB, EQR, and ESS will be crucial; their ability to meet or exceed earnings expectations could provide momentum for VMRK.